When a bone breaks badly — a fracture too severe to heal on its own, or a gap left behind after tumor removal — surgeons face a set of imperfect options. They can harvest bone from elsewhere in the patient’s body, a painful procedure that leaves a permanent defect at the donor site. They can use metal or ceramic implants, which are mechanically strong but rigid and biologically inert. Or they can pack the gap with donor bone chips, which work for smaller voids but can’t restore large segments.

“There’s nothing in terms of treating a big bone gap that would give what you call biologic healing,” meaning new, living, vascularized bone rather than inert filler, said Lukas Nystrom, MD, an orthopedic surgeon at Cleveland Clinic, Cleveland.

Now, a team at ETH Zürich has developed a potential solution that looks nothing like a traditional implant: A hydrogel scaffold made of 97% water and just 3% polymer that can be laser printed into structures fine enough to mimic the microscopic architecture of bone. In a study published in Advanced Materials, the researchers showed that bone-forming cells readily colonized the scaffold and began producing collagen — a key building block of natural bone.

Soft by Design

The idea of using a gelatinous material to repair something as mechanically demanding as bone sounds counterintuitive. But the researchers took their cue from how the body heals.

“The biology of bone fracture healing always starts from a very soft, actually hydrogel-like material,” said Xiao-Hua Qin, PhD, the study’s senior author and a biomaterials engineer at ETH Zürich, Zürich, Switzerland. When someone breaks a bone, the first thing the body produces is a soft, permeable hematoma — a bruise-like scaffold that attracts immune cells, nutrients, and the precursors of new bone. Only later does that soft matrix gradually mineralize into rigid bone.

Qin explained that this matrix follows Wolff’s law, a foundational principle in bone biology that bone that bears weight grows stronger, bone that doesn’t wastes away. A rigid metal implant, he argued, works against this principle by shielding the surrounding tissue from mechanical stimulus. The hydrogel, by contrast, can deform by 40%-50% under compression without breaking — something a ceramic or titanium implant can’t do.

“Hydrogels have a lot of similar properties in terms of the extracellular matrix of our body, and really the precursor to bone as it’s developing,” said Danielle Benoit, PhD, a hydrogel and bone regeneration researcher at the University of Oregon, Eugene, Oregon, who was not involved in the study. She pointed out that even the periosteum — the thin tissue surrounding bone that is critical for healing — is essentially a hydrogel in its natural state.

A Chemistry Problem, Solved

The team used a technique called two-photon polymerization, in which a tightly focused laser is fired into liquid hydrogel, solidifying only the tiny point where the beam converges — leaving everything else untouched. By steering the beam through the material, the researchers can “write” intricate three-dimensional structures with features as small as 500 nm.

Previous approaches using this technique required high polymer concentrations — often 20%-50% — to achieve good print fidelity, resulting in stiffer gels that don’t mimic early bone tissue. The problem was in the crosslinking chemistry, Qin explained.

Qin’s team engineered a new linking molecule — a macromolecular thiol that is a larger, sturdier version of the short-chain compounds other labs had been using — that could carry multiple reactive sites while remaining stable in water.

“The synthesis of polymers with multiple thiol groups has been very challenging,” Qin said. He compared the breakthrough to finding the right cooking technique: The chemistry had to be just right to get stable, water-soluble molecules that could still react efficiently under laser light.

The result is a complex hydrogel structure printed at scanning speeds of up to 400 mm/sec, at just 3% polymer concentration. Benoit called it “really compelling,” noting that the low polymer content and high precision together represent a meaningful advance. She added that macromolecular crosslinking systems are, in her view, “certainly more powerful” than small-molecule approaches, offering greater potential for healing.

Making Bone Cells Feel at Home

Because the hydrogel is synthetic, cells don’t naturally interact with it. To overcome this, the team functionalized the scaffold with a short peptide sequence (RGD) that mimics fibronectin, a protein the body uses to control cell adhesion. With this modification, bone-forming cells called osteoblasts readily colonized the printed structures and began depositing collagen, with no signs of toxicity in vitro.

The idea, Qin said, is to create an implant that is “biologically instructive” — one that doesn’t simply fill a gap and hope for the best but actively guides cellular behavior in a controlled way. “We even want this implant to take into account how cells will interact with the scaffold, ideally in a very controlled fashion,” he said.

The Long Road to the Operating Room

Thein vitro results are promising, but this work is far from clinical use.

Nystrom noted that the clinical need is real. “If there’s a solution that is able to manage segmental bone defects with the potential to create viable, vascularized, normal bony tissue, that would be a massive leap forward in our field,” he said. But he noted he was unclear whether this particular hydrogel could manage such a defect based on the current data. “If this is a step toward that, it would be massively important.”

Benoit emphasized that the critical next step is moving into animal models. “My philosophy always is, with new materials, to get that in vivo result as soon as you can,” she said.

She outlined what researchers should look for in preclinical studies: vascularization of the implant, mineralization, deposition of tissues that are precursors to mature bone, and whether those tissues convert appropriately into osseous tissue. And before any of that, a more basic question: “Is there an egregious inflammatory response that’s going to preclude healing?”

Qin and his colleagues are now collaborating with the AO Research Institute Davos to begin animal studies. His longer-term vision is personalized implants: integrating the printing technology with medical imaging so that a hydrogel scaffold could be fabricated to match the exact geometry of a patient’s injury. Different patients — older vs younger, chronically ill vs healthy — might require different biologic enhancements, potentially including established therapeutics like bone morphogenetic protein 2.

Cell-Free Approaches to Bone Healing May Come First

One broader question hanging over the field is whether hydrogel implants will ultimately need to be seeded with living cells before implantation, or whether cell-free scaffolds that recruit the body’s own cells can be effective enough.

Benoit said cell-based therapies face significant regulatory hurdles around patient-to-patient variability, potency testing, and reproducibility. Cell-free approaches sidestep many of those challenges. “I think likely we’ll see more cell-free first in the market,” she said, because of manufacturing, logistics, and regulations. But she acknowledged the tradeoff: “If you don’t have a robust recruitment of cells, you’re not going to get regeneration, and you might end up with fibrotic tissue that is inferior to the mature tissue that’s necessary.”

For now, the ETH Zürich hydrogel remains a laboratory achievement that still needs to prove itself in living bone. But for a field where, as Nystrom put it, “nothing meaningful” has changed in the treatment of segmental bone defects, a step in that direction matters.

“Anything that will work instead of autograft, I think, will be great,” Qin said.

Nystrom and Benoit reported having no financial conflicts. Disclosure information for Qin and other study authors is available in the original study publication.